Takeda gets Shire clearance from China

|About: Shire PLC (SHPG)|By:, SA News Editor

Bringing it closer to becoming a global top 10 drugmaker, Takeda Pharmaceutical (OTCPK:TKPYY) has received approval from China's market regulator for its $62B acquisition of Shire (NASDAQ:SHPG).

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the U.S. and Brazil and awaits approval from Japan and the EU.

SHPG +1.6% premarket

Subscribe for full text news in your inbox